FDA Inspection 1021086 — Novartis Pharma AG
The FDA completed an inspection of Novartis Pharma AG on Jul 6, 2017 in Basel Town. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 6, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Basel Town (Switzerland)